Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Synapsins × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 433 Carboplatin 303 Specimen Handling 298 Cisplatin 266 Magnetic Resonance Spectroscopy 261 Nivolumab 253 Cyclophosphamide 240 Paclitaxel 213 Radiotherapy 204 Biopsy 181 Gemcitabine 177 Bevacizumab 166 Dexamethasone 146 durvalumab 137 Rituximab 131 Capecitabine 130 atezolizumab 129 Oxaliplatin 128 Docetaxel 128 Fluorouracil 124 venetoclax 123 Drug Therapy 115 Ipilimumab 114 Etoposide 111 Lenalidomide 105 Prednisone 102 Doxorubicin 102 Radiosurgery 96 fludarabine 93 Pemetrexed 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡